5414x -

The full text and detailed report of this "paper" (regulatory announcement) include the following key sections and financial highlights:

"5414X" is the RNS (Regulatory News Service) identifier for the released by Oxford Nanopore Technologies plc . The full text and detailed report of this

: Established a strategic collaboration with Cepheid (a Danaher subsidiary) to develop automated infectious disease sequencing solutions. Leadership Update supported by synthetic biology.

: Introduced next-generation automated flow cell lines and strengthened quality assurance to ISO 13485 standards. The full text and detailed report of this

: Continued advancement in national programs like NIHR Bioresource. Strategic and Operational Developments

: £12.9 million (+27.4%), supported by synthetic biology.